Summary
3H-Domperidone, a potent antagonist of dopamine but less lipophilic than neuroleptic drugs, was studied as a potential ligand for cerebral dopamine receptors. It labeled with high affinity an apparently homogeneous population of non-interacting sites in a particulate fraction of mouse striatum. Association occurred rapidly and dissociation was relatively slow (t1/2≃4min); this allowed extensive washing of membranes which reduced the non-specific binding to values as low as 5% of the total binding. Consistent Kd values of 0.7 nM were obtained by analysing by various methods either the kinetics of binding or the saturation of binding sites at equilibrium.
The relative potencies of various dopamine receptor agonists or antagonists to inhibit 3H-domperidone binding, paralleled their pharmacological activity. On the other hand, a variety of non-dopaminergic agents failed to inhibit 3H-domperidone binding. The findings indicate that striatal dopamine receptors are selectively labeled by this 3H-ligand.
In various non-striatal regions of mouse brain the saturable binding of 3H-domperidone was almost entirely inhibited by apomorphine indicating its selectivity for dopamine receptors in spite of the low density of the latter. This was not the case for the binding of 3H-spiperone, evaluated on the same preparations, indicating that 3H-domperidone probably represents the most selective ligand presently available.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baudry, M., Martres, M. P., Schwartz, J. C.: In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists. Life Sci. 21, 1163–1170 (1977)
Baudry, M., Martres, M. P., Schwartz, J. C.: Dopaminergic receptors studied in vitro and in vivo with radioactive ligands. In: Proceedings of the 4th International Catecholamine Symposium. Pacific Grove, California, 17–22 Sept., 1978
Burt, D. R., Enna, S. J., Creese, I., Snyder, S. H.: Dopamine receptor binding in the corpus striatum of mammalian brain. Proc. Natl. Acad. Sci USA 72, 4655–4659 (1975)
Burt, D. R., Creese, I., Snyder, S. H.: Properties of 3H-haloperidol and 3H-dopamine binding associated with dopamine receptors in calf brain membranes. Mol. Pharmacol. 12, 800–812 (1976)
Chang, K. J., Jacobs, S., Cuatrecasas, P.: quantitative aspects of hormone-receptor interactions of high affinity. Effect of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones. Biochim. Biophys. Acta 406, 294–303 (1975)
Costall, B., Fortune, D. H., Naylor, R. J.: Neuropharmacological studies on the neuroleptic potential of domperidone (R33,812). J. Pharm. Pharmacol. (in press, 1979)
Creese, I., Snyder, S. H.: 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur. J. Pharmacol. 49, 201–202 (1978)
Creese, I., Burt, D. R., Snyder, S. H.: Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. Life Sci. 17, 993–1002 (1975)
Leysen, J. E., Gommeren, W.: Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex. Life Sci. 23, 447–452 (1978)
Leysen, J. E., Gommeren, W., Laduron, P. M.: Spiperone: a ligand of choice for neuroleptic receptors. I. Kinetics and characteristics of in vitro binding. Biochem. Pharmacol. 27, 307–316 (1978a)
Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., Laduron, P. M.: Serotonergic component of neuroleptic receptors. Nature 272, 168–171 (1978b)
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Martres, M. P., Baudry, M., Schwartz, J. C.: Characterization of 3H-domperidone binding on striatal dopamine receptors. Life Sci. 23, 1781–1784 (1978)
Nagy, J. I., Lee, T., Seeman, P., Fibiger, H. C.: Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature 274, 278–281 (1978)
Niemegeers, C. J. E., Janssen, P. A. J.: The antiemetic properties of domperidone, a novel potent gastrokinetic. In: Proceedings of the 7th International Congress of Pharmacology. Abstract no68. Paris, France, 16–21 July, 1978
Parker, R. B., Waud, D. R.: Pharmacological estimation of drug-receptor dissociation constants. — Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther. 177, 1–12 (1971)
Schwarcz, R., Creese, I., Coyle, J. T., Snyder, S. H.: Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature 271, 766–768 (1978)
Schwartz, J. C., Baudry, M., Martres, M. P., Costentin, J., Protais, P.: Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol. Life Sci. 23, 1785–1790 (1978)
Seeman, P.: Antischizophrenic drugs. — Membrane receptor sites of action. Biochem. Pharmacol. 26, 1741–1748 (1977)
Seeman, P., Chau-Wong, M., Tedesco, J., wong, K.: Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc. Natl. Acad. Sci. USA 72, 4376–4380 (1975)
Seeman, P., Lee, T., Chau-Wong, M., Tedesco, J., Wong, K.: Dopamine receptors in human and calf brains, using 3H-apomorphine and an antipsychotic drug. Proc. Natl. Acad. Sci USA. 73, 4354–4358 (1976)
Seeman, P., Tedesco, J. L., Lee, T., Chau-Wong, M., Muller, P., Bowles, J., Whitaker, P. M., McManus, C., Titeler, M., Weinrich, P., Friend, W. C., Brown, G. M.: Dopamine receptors in the central nervous system. Fed. Proc. 37, 130–136 (1978)
Snyder, S. H., Creese, I., Burt, D. R.: The brain dopamine receptor: labeling with 3H-dopamine and 3H-haloperidol. Psychopharmacol. Commun. 1, 663–673 (1975)
Titeler, M., Weinrich, P., Sinclair, D., Seeman, P.: Multiple receptors for brain dopamine. Proc. Natl. Acad. Sci. USA 75, 1153–1156 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baudry, M., Martres, M.P. & Schwartz, J.C. 3H-Domperidone: A selective ligand for dopamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 308, 231–237 (1979). https://doi.org/10.1007/BF00501387
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501387